Sign In

The Michaelis constant (KM) and the theoretical maximum process rate (Vmax) are vital parameters in the Michaelis-Menten equation, central to many biochemical reactions. They provide essential insights into enzyme kinetics and drug metabolism.

These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two different dose regimens until a steady-state concentration (Css) is reached.

A direct linear plot method determines the KM and Vmax in phenytoin-administered patients. This involves plotting two steady-state concentrations (Css) and their corresponding dosing rates (DR). The lines formed by joining these points are then extrapolated to obtain the values for KM and Vmax.

Several other methods can also be employed to estimate these parameters. One such method is the Lineweaver Burk plot, which plots the reciprocal of the dosing rate versus the steady-state concentration. In this plot, the slope of the line is equal to KM/Vmax, and the y-intercept is 1/Vmax. This means that both parameters can be readily estimated from this plot.

Another method involves plotting the dosing rate (DR) against the ratio of the dosing rate to the steady-state concentration (DR/Css). This method, typically referred to as the Eadie-Hofstee plot, allows for determining both KM and Vmax. The slope of the line obtained from this plot is -KM, while the y-intercept is Vmax.

It's important to note that in clinical settings, the value of KM can vary among patients. Typically, patients with lower KM values tend to experience larger shifts in plasma concentrations during dosage adjustments. They also exhibit a more significant change in the rate of drug elimination compared to those with higher KM values. This variability in KM values underscores the importance of personalized medicine and dosage adjustments.

From Chapter 8:

article

Now Playing

8.4 : Determination of Michaelis Constant and Maximum Elimination Rate

Nonlinear Pharmacokinetics

32 Views

article

8.1 : Nonlinear Pharmacokinetics: Overview

Nonlinear Pharmacokinetics

143 Views

article

8.2 : Nonlinear Pharmacokinetics: Causes of Nonlinearity

Nonlinear Pharmacokinetics

50 Views

article

8.3 : Nonlinear Pharmacokinetics: Michaelis-Menten Equation

Nonlinear Pharmacokinetics

83 Views

article

8.5 : Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection

Nonlinear Pharmacokinetics

14 Views

article

8.6 : Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview

Nonlinear Pharmacokinetics

16 Views

article

8.7 : Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

Nonlinear Pharmacokinetics

18 Views

article

8.8 : Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

Nonlinear Pharmacokinetics

27 Views

article

8.9 : Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Nonlinear Pharmacokinetics

28 Views

article

8.10 : Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Nonlinear Pharmacokinetics

40 Views

article

8.11 : Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding

Nonlinear Pharmacokinetics

59 Views

article

8.12 : Nonlinear Pharmacokinetics: Role of Transporters

Nonlinear Pharmacokinetics

16 Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved